Home › Funds › Paradigm Biocapital Advisors LP › GPCR

Paradigm Biocapital Advisors LP position in GPCR

STRUCTURE THERAPEUTICS INC · Health Care

Paradigm Biocapital Advisors LP reported holding 1,299,199 shares of GPCR (STRUCTURE THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$40.6M, representing 0.81% of its reported portfolio and ranking #18 among its reported holdings. Paradigm Biocapital Advisors LP has disclosed GPCR holdings in 3 of the last 5 reported quarters, going back to Q3 2025.

Latest position (Q3 2026)1.30M sh
Reported value held$40.63M
Portfolio Weight0.81%
First reportedQ3 2025
Last changeNew
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Paradigm Biocapital Advisors LP's GPCR position evolved

Paradigm Biocapital Advisors LP first disclosed a stake in GPCR in Q3 2025 at 372,869 shares (US$10.4M). The position peaked in Q3 2026 at 1,299,199 shares, worth US$40.6M. Across 3 filings, Paradigm Biocapital Advisors LP held the position steady without any share-count change. The most recent filing (Q3 2026) shows 1,299,199 shares valued at US$40.6M.

Quarter by quarter

QuarterSharesValueChange
Q3 2025 372.87K $10.44M New
Q1 2026 545.29K $26.28M New
Q3 2026 1.30M $40.63M New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GPCR and 13F data

GPCR (STRUCTURE THERAPEUTICS INC) is a Health Care company. 25 other funds we track also report a position in GPCR — the largest reported positions include Avoro Capital Advisors LLC (US$205.0M), BVF INC/IL (US$180.7M), Deep Track Capital, LP (US$156.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GPCR

All GPCR fund holders →

FAQ

How long has Paradigm Biocapital Advisors LP held GPCR?

Paradigm Biocapital Advisors LP has disclosed GPCR holdings in 3 of the last 5 reported quarters, going back to Q3 2025.

What is Paradigm Biocapital Advisors LP's current position in GPCR?

As of Q3 2026, Paradigm Biocapital Advisors LP holds 1.30M shares of GPCR (STRUCTURE THERAPEUTICS INC), valued at $40.63M, representing 0.81% of its reported portfolio and ranking #18.

Has Paradigm Biocapital Advisors LP been buying or selling GPCR?

In the latest 13F filing (Q3 2026), Paradigm Biocapital Advisors LP newly opened its position in GPCR. The position peaked in Q3 2026 at 1.30M shares.

Which other funds hold GPCR?

Other major institutional holders of GPCR include Avoro Capital Advisors LLC, BVF INC/IL, Deep Track Capital, LP, among 25 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.